Literature DB >> 16539284

Incidence and prevalence of systemic lupus erythematosus in a district of north Italy.

M Govoni1, G Castellino, S Bosi, N Napoli, F Trotta.   

Abstract

The objective of this study was to investigate the incidence and the prevalence of systemic lupus erythematosus (SLE) in an area of northeast Italy. We retrospectively examined all patients of 16 years and older of native Italian origin and resident in Ferrara district either admitted to hospital or referred to our outpatient clinic with a diagnosis of SLE determined between 1 January 1996 and 31 December 2002. SLE subjects were identified both by a search of hospital discharge code 710.0 according to the international classification of diseases-9 codes, and using a computerized search for this pathology code in the national health care system. Incidence and prevalence rates were calculated as number of cases per 100 000 inhabitants. Population data were based on the 2002 National Census. A total of 299 cases of SLE were identified. After a review of all cases by one experienced investigator, 98 were excluded because did not satisfied the 1982 revised criteria of the American College Rheumatology. Therefore, 201 patients had a definite diagnosis of SLE. The prevalence of SLE in the district was 57.9/100 000. The mean age at diagnosis was 41 years, the average duration of the disease from symptoms onset to diagnosis was 4.8 years and the female/male ratio 9:1. Annual incidence in 2000 was 2.01/100000, in 2001 1.15/100000 and in 2002 2.6/100000. This is the first study dealing with prevalence and incidence of SLE in an Italian district. Data obtained concerning prevalence, incidence, age at diagnoses and female predominance are in agreement with those published in literature.

Entities:  

Mesh:

Year:  2006        PMID: 16539284     DOI: 10.1191/0961203306lu2235xx

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  10 in total

1.  The prevalences of some rheumatic diseases in western Turkey: Havsa study.

Authors:  Necati Cakır; Ömer Nuri Pamuk; Emine Derviş; Neşe Imeryüz; Haşim Uslu; Ömer Benian; Edip Elelçi; Genco Erdem; Fatma Oğuz Sarvan; Mustafa Senocak
Journal:  Rheumatol Int       Date:  2011-01-13       Impact factor: 2.631

2.  Estimating disease prevalence and incidence using administrative data: some assembly required.

Authors:  Michael M Ward
Journal:  J Rheumatol       Date:  2013-08       Impact factor: 4.666

Review 3.  The global burden of SLE: prevalence, health disparities and socioeconomic impact.

Authors:  Erin E Carter; Susan G Barr; Ann E Clarke
Journal:  Nat Rev Rheumatol       Date:  2016-08-25       Impact factor: 20.543

4.  Prevalence and incidence of systemic lupus erythematosus in South Korea.

Authors:  Jee-Seon Shim; Yoon-Kyoung Sung; Young Bin Joo; Hye-Soon Lee; Sang-Cheol Bae
Journal:  Rheumatol Int       Date:  2013-12-10       Impact factor: 2.631

5.  Epidemiology of systemic lupus erythematosus: capturing the butterfly.

Authors:  S Sam Lim; Cristina Drenkard
Journal:  Curr Rheumatol Rep       Date:  2008-08       Impact factor: 4.592

6.  The prevalence of rheumatic diseases in central Greece: a population survey.

Authors:  Ioannis Anagnostopoulos; Elias Zinzaras; Ioannis Alexiou; Aphrodite A Papathanasiou; Evangelos Davas; Athanasios Koutroumpas; Georgia Barouta; Lazaros I Sakkas
Journal:  BMC Musculoskelet Disord       Date:  2010-05-26       Impact factor: 2.362

7.  Incidence and prevalence of lupus in Buenos Aires, Argentina: a 11-year health management organisation-based study.

Authors:  M Scolnik; J Marin; S M Valeiras; M F Marchese; A S Talani; N L Avellaneda; A Etchepare; P Etchepare; M S Plou; E R Soriano
Journal:  Lupus Sci Med       Date:  2014-06-05

8.  Trend of prevalence and incidence of systemic lupus erythematosus in South Korea, 2005 to 2015: a nationwide population-based study.

Authors:  Eun Hui Bae; Sang Yeob Lim; Kyung-Do Han; Jin-Hyung Jung; Hong Sang Choi; Ha Yeon Kim; Chang Seong Kim; Seong Kwon Ma; Soo Wan Kim
Journal:  Korean J Intern Med       Date:  2019-06-21       Impact factor: 2.884

9.  Clinical and epidemiological features of rheumatic diseases in patients attending the university hospital in Kinshasa.

Authors:  J J Malemba; J M Mbuyi-Muamba
Journal:  Clin Rheumatol       Date:  2007-06-02       Impact factor: 3.650

10.  Health technology assessment of belimumab: a new monoclonal antibody for the treatment of systemic lupus erythematosus.

Authors:  Maria Lucia Specchia; Chiara de Waure; Maria Rosaria Gualano; Andrea Doria; Giuseppe Turchetti; Lara Pippo; Francesco Di Nardo; Silvio Capizzi; Chiara Cadeddu; Flavia Kheiraoui; Luca Iaccarino; Francesca Pierotti; Ilaria Palla; Maria Assunta Veneziano; Daniela Gliubizzi; Antonella Sferrazza; Nicola Nicolotti; Rolando Porcasi; Giuseppe La Torre; Maria Luisa Di Pietro; Walter Ricciardi
Journal:  Biomed Res Int       Date:  2014-08-17       Impact factor: 3.411

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.